Publications 2022

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2022)
Re: Writing committee for the Post-Injection Endophthalmitis Study Group, et al.: The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections (Ophthalmology. 2021;128:1620-1626)
Ophthalmology, 129 (5), e61-e62
DOI 10.1016/j.ophtha.2022.01.017, PubMed 35232584

Blom K, Jørstad ØK, Faber RT, Stene-Johansen I, Holberg-Petersen M, Hermansen NO, Bragadóttir R (2022)
Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study
Acta Ophthalmol, 101 (1), 100-108
DOI 10.1111/aos.15207, PubMed 35751448

Publications 2021

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2021)
Mask use by patients in the context of COVID-19 can increase the risk of postinjection endophthalmitis
Acta Ophthalmol, 100 (3), e859-e860
DOI 10.1111/aos.14945, PubMed 34155818

Publications 2020

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2020)
Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?
Ocul Immunol Inflamm, 30 (3), 713-716
DOI 10.1080/09273948.2020.1820530, PubMed 33026900

Publications 2019

Blom K, Jørstad ØK, Bragadóttir R (2019)
Endophthalmitis in Oslo, Norway
Acta Ophthalmol, 97 (7), 695-699
DOI 10.1111/aos.14028, PubMed 30816017